BioRestorative Therapies (BRTX) Total Debt (2010 - 2025)

BioRestorative Therapies (BRTX) has reported Total Debt for 16 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Total Debt fell 44.49% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 44.49% YoY), and the FY2025 full-year result was $1.4 million, down 44.49% from the prior year.
• Total Debt fell to $1.4 million in Q4 2025 per BRTX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Total Debt topped out at $14.2 million in Q1 2022 and bottomed at $308970.0 in Q4 2021.
• Historically, Total Debt has averaged $4.6 million across 5 years, with a median of $4.0 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Total Debt sank 92.76% in 2021, then surged 1693.62% in 2022.
• Over 5 years, Total Debt stood at $308970.0 in 2021, then soared by 1693.62% to $5.5 million in 2022, then tumbled by 72.14% to $1.5 million in 2023, then jumped by 63.27% to $2.5 million in 2024, then tumbled by 44.49% to $1.4 million in 2025.
• According to Business Quant data, Total Debt over the past three periods registered $1.4 million, $2.0 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.